Amphastar Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 13.9% | 11.9% | 9.2% |
| FY2022 | 17.3% | 15.1% | 12.3% |
| FY2023 | 21.5% | 11.1% | 9.1% |
| FY2024 | 21.8% | 11.9% | 10.1% |
| FY2025 | 12.4% | 7.0% | 6.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 13.9% | 11.9% | 9.2% |
| FY2022 | 17.3% | 15.1% | 12.3% |
| FY2023 | 21.5% | 11.1% | 9.1% |
| FY2024 | 21.8% | 11.9% | 10.1% |
| FY2025 | 12.4% | 7.0% | 6.0% |